Researchers are studying the evolution of myeloid leukemia in individuals with Down syndrome, with a focus on understanding the cellular and molecular mechanisms involved. Single-cell transcriptional analysis is being used to map the progression of the disease and identify potential factors contributing to its development. The research aims to shed light on the underlying biology of leukemia in Down syndrome, which may have implications for understanding and addressing therapy resistance.